Primecap Management CO Elanco Animal Health Inc Transaction History

Primecap Management CO

$118 Billion
Q1 2025

A detailed history of Primecap Management CO transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Primecap Management CO holds 50,223,535 shares of ELAN stock, worth $649 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

50,223,535

Previous 51,165,165 1.84%

Holding current value

$649 Million

Previous $620 Million 14.89%

% of portfolio

0.45%

Previous 0.49%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$10.04 - $12.47 $9.45 Million - $11.7 Million	-941,630 Reduced 1.84%	50,223,535 $527 Million
Q4 2024 Feb 10, 2025	SELL	$11.63 - $14.67 $16.4 Million - $20.7 Million	-1,410,337 Reduced 2.68%	51,165,165 $620 Million
Q3 2024 Nov 08, 2024	SELL	$11.85 - $15.47 $2.69 Million - $3.52 Million	-227,261 Reduced 0.43%	52,575,502 $772 Million
Q2 2024 Aug 09, 2024	SELL	$12.93 - $18.45 $1.06 Million - $1.52 Million	-82,305 Reduced 0.16%	52,802,763 $762 Million
Q1 2024 May 13, 2024	BUY	$14.37 - $16.46 $32.8 Million - $37.6 Million	2,284,744 Added 4.52%	52,885,068 $861 Million
Q4 2023 Feb 09, 2024	BUY	$8.6 - $14.94 $12.3 Million - $21.4 Million	1,431,665 Added 2.91%	50,600,324 $754 Million
Q3 2023 Nov 13, 2023	BUY	$9.81 - $12.62 $1.69 Million - $2.17 Million	172,205 Added 0.35%	49,168,659 $553 Million
Q2 2023 Aug 11, 2023	BUY	$8.08 - $10.37 $42 Million - $53.9 Million	5,195,245 Added 11.86%	48,996,454 $493 Million
Q1 2023 May 15, 2023	BUY	$8.79 - $14.58 $95.1 Million - $158 Million	10,817,647 Added 32.8%	43,801,209 $412 Million
Q4 2022 Feb 13, 2023	BUY	$11.49 - $13.65 $29.4 Million - $34.9 Million	2,560,199 Added 8.42%	32,983,562 $403 Million
Q3 2022 Nov 14, 2022	SELL	$12.41 - $32.42 $1.59 Million - $4.15 Million	-128,102 Reduced 0.42%	30,423,363 $378 Million
Q2 2022 Aug 11, 2022	SELL	$19.63 - $26.62 $4.57 Million - $6.2 Million	-232,827 Reduced 0.76%	30,551,465 $600 Million
Q1 2022 May 11, 2022	BUY	$24.65 - $29.0 $15.4 Million - $18.1 Million	625,326 Added 2.07%	30,784,292 $803 Million
Q4 2021 Feb 11, 2022	SELL	$27.74 - $34.09 $16.5 Million - $20.2 Million	-593,979 Reduced 1.93%	30,158,966 $856 Million
Q3 2021 Nov 12, 2021	SELL	$29.2 - $36.72 $3.42 Million - $4.3 Million	-116,987 Reduced 0.38%	30,752,945 $981 Million
Q2 2021 Aug 10, 2021	SELL	$28.76 - $35.98 $19.9 Million - $24.9 Million	-693,279 Reduced 2.2%	30,869,932 $1.07 Billion
Q1 2021 May 14, 2021	SELL	$27.85 - $34.49 $27 Million - $33.4 Million	-968,000 Reduced 2.98%	31,563,211 $930 Million
Q4 2020 Feb 08, 2021	SELL	$27.53 - $33.79 $29 Million - $35.5 Million	-1,051,864 Reduced 3.13%	32,531,211 $998 Million
Q3 2020 Nov 13, 2020	SELL	$21.1 - $29.13 $13.6 Million - $18.7 Million	-643,180 Reduced 1.88%	33,583,075 $938 Million
Q2 2020 Aug 13, 2020	SELL	$18.94 - $24.93 $3.97 Million - $5.22 Million	-209,504 Reduced 0.61%	34,226,255 $734 Million
Q1 2020 May 14, 2020	BUY	$16.68 - $32.25 $64 Million - $124 Million	3,837,394 Added 12.54%	34,435,759 $771 Million
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $3.87 Million - $4.51 Million	152,983 Added 0.5%	30,598,365 $901 Million
Q3 2019 Nov 13, 2019	SELL	$25.62 - $34.96 $6.73 Million - $9.19 Million	-262,734 Reduced 0.86%	30,445,382 $810 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $3.12 Million - $3.49 Million	100,210 Added 0.33%	30,708,116 $1.04 Billion
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $744 Million - $842 Million	25,645,707 Added 516.82%	30,607,906 $982 Million
Q4 2018 Feb 12, 2019	BUY	$29.63 - $34.5 $35.9 Million - $41.8 Million	1,212,199 Added 32.33%	4,962,199 $156 Million
Q3 2018 Nov 13, 2018	BUY	$34.1 - $36.19 $128 Million - $136 Million	3,750,000 New	3,750,000 $131 Million

Others Institutions Holding ELAN

# of Institutions

410

Shares Held

452M

Call Options Held

718K

Put Options Held

671K

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.13B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Elanco Animal Health Inc Transaction History